|SCPI -- Indonesia Stock|| |
IDR 29,000 0.00 0.00%
Dr. Irsan Budianto Darmadji serves as Independent Commissioner of PT Merck Sharp Dohme Pharma Tbk since December 19, 2011. He has served as a Commissioner of PT Candi Indah, PT Puri International Hotel, PT Putri Gundaling, PT Citra Rapi, PT Grahamas Citrawasata Tbk, PT Sarana Angakasa Transit Hotel, PT Dinar Securities, Creo Planner and PT Astrindo Pacific Finance. He holds MBA in International Business Management from University of San Francisco .
Age: 49 Executive Since 2011 MBA
Merck Sharp Dohme Pharma Tbk (SCPI) is traded on Jakarta Stock Exchange in Indonesia. and employs 5 people.
Merck Sharp Dohme Leadership Team
|Christopher McNamara, Executive, CPA|
|Ashish Pal, President, MBA|
|Ardhi Pradhana, Executive, MBA|
|Novian Zein, Director|
|Ridarrahim Nirwandar, Executive|
|Meau Fon, Director|
|Erwin Agung, Director|
|Irsan Darmadji, Executive, MBA|
|Jan Acker, President|
|Cheung Ling, Director, MBA|
|YuhRu Chen, Director, CPA|
|Ekert Ann, Director|
Stock Performance Indicators
Macroaxis portfolio users are evenly split in their outlook on investing in Merck Sharp Dohme Pharma Tbk. What is your trading attitude regarding investing in Merck Sharp Dohme Pharma Tbk? Are you bullish or bearish?
Also please take a look at World Market Map
. Please also try Insider Screener
module to find insiders across different sectors to evaluate their impact on performance.